One more point for ibrutinib plus rituximab over fludarabine, cyclophosphamide and rituximab (FCR)
@article{ACTR9985, author = {Martin Gauthier and Christian Koba}, title = {One more point for ibrutinib plus rituximab over fludarabine, cyclophosphamide and rituximab (FCR)}, journal = {AME Clinical Trials Review}, volume = {2}, number = {0}, year = {2024}, keywords = {}, abstract = {}, issn = {3005-6152}, url = {https://actr.amegroups.org/article/view/9985} }